#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	1	0	27	370	AAC_2___Ic	546	546	100.0	AAC_2___Ic.l15.c4.ctg.1	1292	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AAC(2')-Ic;b"AAC(2')-Ic is a chromosomal-encoded aminoglycoside acetyltransferase in M. tuberculosis and Mycobacterium tuberculosis variant bovis."
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	42	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c30.ctg.1	490	0.0	0	.	n	.	0	C69T	SNP	69	69	C	440	440	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	42	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c30.ctg.1	490	0.0	0	.	n	.	0	G72.	DEL	72	72	G	442	442	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	42	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c30.ctg.1	490	0.0	0	.	n	.	0	T74.	DEL	74	74	T	443	443	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	42	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c30.ctg.1	490	0.0	0	.	n	.	0	T77C	SNP	77	77	T	446	446	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	42	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c30.ctg.1	490	0.0	0	.	n	.	0	G81A	SNP	81	81	G	449	449	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	42	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c30.ctg.1	490	0.0	0	.	n	.	0	G83A	SNP	83	83	G	451	451	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	42	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c30.ctg.1	490	0.0	0	.	n	.	0	G85A	SNP	85	85	G	453	453	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	42	Cutibacterium_acnes_16S	1486	115	91.3	Cutibacterium_acnes_16S.l6.c30.ctg.1	490	0.0	0	.	n	.	0	C112A	SNP	112	112	C	480	480	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Erm_37_.3000392.AL123456.1.2231679_2232219.582	Erm_37_.3000392.AL123456.1.2231679_2232219.582	1	0	27	318	Erm_37_	540	540	100.0	Erm_37_.l15.c4.ctg.1	1425	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Erm(37);b'Erm(37) is found in Mycobacterium species and confers the MLSb phenotype. In addition to methylation of A2058 this Erm methylates adjacent adenosines (A2057 and A2059) as well.'
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	337	98.81	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	337	0.0	0	.	n	.	0	T1539C	SNP	1539	1539	T	19	19	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	337	98.81	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	337	0.0	0	.	n	.	0	A1582G	SNP	1582	1582	A	62	62	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	337	98.81	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	337	0.0	0	.	n	.	0	A1744G	SNP	1744	1744	A	224	224	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	337	98.81	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	337	0.0	0	.	n	.	0	T1751C	SNP	1751	1751	T	231	231	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	C2346T	SNP	2346	2346	C	20	20	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A2347C	SNP	2347	2347	A	21	21	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	T2358G	SNP	2358	2358	T	32	32	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A2361G	SNP	2361	2361	A	35	35	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	T2362C	SNP	2362	2362	T	36	36	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A2399G	SNP	2399	2399	A	73	73	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	C2402T	SNP	2402	2402	C	76	76	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	G2408C	SNP	2408	2408	G	82	82	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	T2418A	SNP	2418	2418	T	93	93	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	C2427T	SNP	2427	2427	C	102	102	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	C2429G	SNP	2429	2429	C	104	104	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A2526G	SNP	2526	2526	A	201	201	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	G2536A	SNP	2536	2536	G	211	211	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	C2593T	SNP	2593	2593	C	268	268	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A2895G	SNP	2895	2895	A	570	570	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	T2896C	SNP	2896	2896	T	571	571	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	T2906C	SNP	2906	2906	T	581	581	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A2909G	SNP	2909	2909	A	584	584	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A2915G	SNP	2915	2915	A	590	590	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	G2920C	SNP	2920	2920	G	595	595	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A2940T	SNP	2940	2940	A	615	615	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	T3002C	SNP	3002	3002	T	677	677	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A3005G	SNP	3005	3005	A	680	680	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A3007T	SNP	3007	3007	A	682	682	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	C3028A	SNP	3028	3028	C	703	703	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	G3038A	SNP	3038	3038	G	713	713	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	T3045C	SNP	3045	3045	T	720	720	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	C3062T	SNP	3062	3062	C	737	737	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A3067G	SNP	3067	3067	A	742	742	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	C3071T	SNP	3071	3071	C	746	746	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	777	95.12	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	881	0.0	0	.	n	.	0	A3083G	SNP	3083	3083	A	758	758	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	167	97.6	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.3	287	0.0	0	.	n	.	0	T8C	SNP	8	8	T	128	128	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	167	97.6	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.3	287	0.0	0	.	n	.	0	A96G	SNP	96	96	A	216	216	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	167	97.6	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.3	287	0.0	0	.	n	.	0	T98G	SNP	98	98	T	218	218	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	46	Mycobacterium_intracellulare_23S_1	3103	167	97.6	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.3	287	0.0	0	.	n	.	0	T146C	SNP	146	146	T	266	266	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	A2347G	SNP	2347	2347	A	22	22	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	T2361C	SNP	2361	2361	T	36	36	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	A2398G	SNP	2398	2398	A	73	73	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	C2401T	SNP	2401	2401	C	76	76	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	G2407C	SNP	2407	2407	G	82	82	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	C2427T	SNP	2427	2427	C	102	102	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	C2429G	SNP	2429	2429	C	104	104	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	G2536A	SNP	2536	2536	G	211	211	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	C2563T	SNP	2563	2563	C	238	238	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	C2593T	SNP	2593	2593	C	268	268	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	T2609C	SNP	2609	2609	T	284	284	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	T2611C	SNP	2611	2611	T	286	286	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	G2841A	SNP	2841	2841	G	516	516	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	A2892G	SNP	2892	2892	A	567	567	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	A2909G	SNP	2909	2909	A	584	584	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	T2931C	SNP	2931	2931	T	606	606	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	A2940T	SNP	2940	2940	A	615	615	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	C2991T	SNP	2991	2991	C	666	666	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	G3038A	SNP	3038	3038	G	713	713	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	C3044T	SNP	3044	3044	C	719	719	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	A3067G	SNP	3067	3067	A	742	742	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	A3071T	SNP	3071	3071	A	746	746	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	A3083G	SNP	3083	3083	A	758	758	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	784	96.81	Mycobacterium_kansasii_23S.l15.c4.ctg.1	795	0.0	0	.	n	.	0	C3103.	DEL	3103	3103	C	777	777	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	A220G	SNP	220	220	A	60	60	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	A231T	SNP	231	231	A	71	71	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	T241C	SNP	241	241	T	81	81	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	T268.	DEL	268	268	T	107	107	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	C326G	SNP	326	326	C	164	164	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	C331T	SNP	331	331	C	169	169	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	T340G	SNP	340	340	T	178	178	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	G354A	SNP	354	354	G	192	192	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	A379G	SNP	379	379	A	217	217	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	T428C	SNP	428	428	T	266	266	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	T448A	SNP	448	448	T	286	286	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	T485C	SNP	485	485	T	323	323	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	T496C	SNP	496	496	T	334	334	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	421	96.2	Mycobacterium_kansasii_23S.l15.c4.ctg.2	419	0.0	0	.	n	.	0	A546T	SNP	546	546	A	384	384	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	170	98.82	Mycobacterium_kansasii_23S.l15.c4.ctg.3	287	0.0	0	.	n	.	0	A74T	SNP	74	74	A	191	191	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	170	98.82	Mycobacterium_kansasii_23S.l15.c4.ctg.3	287	0.0	0	.	n	.	0	T149C	SNP	149	149	T	266	266	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	T1536C	SNP	1536	1536	T	19	19	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	T1561C	SNP	1561	1561	T	44	44	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	C1564T	SNP	1564	1564	C	47	47	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	C1587T	SNP	1587	1587	C	70	70	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	T1588C	SNP	1588	1588	T	71	71	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	G1602A	SNP	1602	1602	G	85	85	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	G1625A	SNP	1625	1625	G	108	108	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	C1645T	SNP	1645	1645	C	128	128	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	A1681T	SNP	1681	1681	A	164	164	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	A1715T	SNP	1715	1715	A	198	198	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	C1731T	SNP	1731	1731	C	214	214	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	A1741G	SNP	1741	1741	A	224	224	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	C1795T	SNP	1795	1795	C	278	278	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	54	Mycobacterium_kansasii_23S	3118	333	94.89	Mycobacterium_kansasii_23S.l15.c4.ctg.4	337	0.0	0	.	n	.	0	G1817A	SNP	1817	1817	G	300	300	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	531	662	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	99.92	Mycobacterium_tuberculosis_Rv1258c_1.l6.c4.ctg.1	2468	0.0	0	.	p	.	0	E194fs	FSHIFT	580	580	G	1020	1020	C	ND	ND	ND	.	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	716	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2615	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	628	630	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	716	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2615	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	643	645	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	716	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2615	0.0	1	SNP	p	L50V	0	.	.	148	150	CTG	739	741	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:L50V:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	716	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2615	0.0	1	SNP	p	T110A	0	.	.	328	330	ACC	919	921	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:T110A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	716	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2615	0.0	1	SNP	p	R268H	0	.	.	802	804	CGC	1393	1395	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R268H:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	716	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2615	0.0	1	SNP	p	A300P	0	.	.	898	900	GCC	1489	1491	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:A300P:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	716	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2615	0.0	1	SNP	p	G313R	0	.	.	937	939	GGG	1528	1530	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G313R:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	716	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2615	0.0	1	SNP	p	G339A	0	.	.	1015	1017	GGG	1606	1608	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G339A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	C69T	SNP	69	69	C	394	394	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	.75A	INS	75	75	G	401	401	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	G77A	SNP	77	77	G	403	403	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	T129C	SNP	129	129	T	455	455	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	C174G	SNP	174	174	C	500	500	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	C176A	SNP	176	176	C	502	502	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	T178G	SNP	178	178	T	504	504	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	G183T	SNP	183	183	G	509	509	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	A186T	SNP	186	186	A	512	512	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	C193G	SNP	193	193	C	519	519	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	.196GC	INS	196	196	A	523	523	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	T202A	SNP	202	202	T	530	530	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	T249C	SNP	249	249	T	577	577	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	C254T	SNP	254	254	C	582	582	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	355	93.59	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	683	0.0	0	.	n	.	0	A291T	SNP	291	291	A	619	619	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	220	98.18	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	220	0.0	0	.	n	.	0	A575T	SNP	575	575	A	19	19	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	220	98.18	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	220	0.0	0	.	n	.	0	A581G	SNP	581	581	A	25	25	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	220	98.18	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	220	0.0	0	.	n	.	0	G593A	SNP	593	593	G	37	37	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	220	98.18	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	220	0.0	0	.	n	.	0	T741G	SNP	741	741	T	185	185	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	98	Mycobacteroides_abscessus_16S_4	1504	84	100.0	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.3	233	0.0	1	SNP	n	G1458U	0	.	.	1458	1458	G	43	43	G	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:G1458U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	.47T	INS	47	47	G	312	312	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	C49T	SNP	49	49	C	314	314	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	G57A	SNP	57	57	G	323	323	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	C108T	SNP	108	108	C	374	374	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	T109C	SNP	109	109	T	375	375	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	A153G	SNP	153	153	A	419	419	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	C156A	SNP	156	156	C	422	422	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	T158G	SNP	158	158	T	424	424	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	G165T	SNP	165	165	G	431	431	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	A166T	SNP	166	166	A	432	432	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	C173G	SNP	173	173	C	439	439	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	.176GC	INS	176	176	A	443	443	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	T182A	SNP	182	182	T	450	450	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	A227G	SNP	227	227	A	495	495	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	T229C	SNP	229	229	T	497	497	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	C234T	SNP	234	234	C	502	502	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	335	93.22	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	603	0.0	0	.	n	.	0	A271T	SNP	271	271	A	539	539	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	220	98.18	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	220	0.0	0	.	n	.	0	A555T	SNP	555	555	A	19	19	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	220	98.18	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	220	0.0	0	.	n	.	0	A561G	SNP	561	561	A	25	25	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	220	98.18	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	220	0.0	0	.	n	.	0	G573A	SNP	573	573	G	37	37	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	90	Mycobacteroides_chelonae_16S_4	1441	220	98.18	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	220	0.0	0	.	n	.	0	T721G	SNP	721	721	T	185	185	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
blaC.3007182.AL123456.3.2325885_2326809.8481	blaC.3007182.AL123456.3.2325885_2326809.8481	1	0	27	496	blaC	924	924	100.0	blaC.l15.c17.ctg.1	1729	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'blaC is a broad-spectrum class A beta-lactamase coded in the chromosome of Mycobacterium tuberculosis. It has been shown to hydrolyze a large number of beta-lactam antibiotics and is a major obstacle in the treatment of tuberculosis with such drugs.';blaC
efpA.3003955.AL123456.3.3153038_3154631.5259	efpA.3003955.AL123456.3.3153038_3154631.5259	1	0	27	722	efpA	1593	1593	100.0	efpA.l15.c17.ctg.1	2184	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'efpA is an MFS transporter found in Mycobacterium tuberculosis.';efpA
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1352	embA	3285	3285	99.97	embA.l6.c4.ctg.1	3967	0.0	1	SNP	p	D4N	0	.	.	10	12	GAC	300	302	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D4N:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1352	embA	3285	3285	99.97	embA.l6.c4.ctg.1	3967	0.0	1	SNP	p	G5S	0	.	.	13	15	GGT	303	305	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G5S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1352	embA	3285	3285	99.97	embA.l6.c4.ctg.1	3967	0.0	1	SNP	p	A201T	0	.	.	601	603	GCG	891	893	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A201T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1352	embA	3285	3285	99.97	embA.l6.c4.ctg.1	3967	0.0	1	SNP	p	G321S	0	.	.	961	963	GGC	1251	1253	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G321S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1352	embA	3285	3285	99.97	embA.l6.c4.ctg.1	3967	0.0	1	SNP	p	G350D	0	.	.	1048	1050	GGC	1338	1340	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G350D:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1352	embA	3285	3285	99.97	embA.l6.c4.ctg.1	3967	0.0	1	SNP	p	A462V	0	.	.	1384	1386	GCG	1674	1676	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A462V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1352	embA	3285	3285	99.97	embA.l6.c4.ctg.1	3967	0.0	1	SNP	p	D833A	0	.	.	2497	2499	GAC	2787	2789	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D833A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1352	embA	3285	3285	99.97	embA.l6.c4.ctg.1	3967	0.0	1	SNP	p	P913S	0	.	.	2737	2739	CCG	3027	3029	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:P913S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	L239P	0	.	.	715	717	CTG	1156	1158	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L239P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	D240H	0	.	.	718	720	GAC	1159	1161	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D240H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	S297A	0	.	.	889	891	TCG	1330	1332	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S297A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	D299E	0	.	.	895	897	GAC	1336	1338	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D299E:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	M306T	0	.	.	916	918	ATG	1357	1359	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306T:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	M306L	0	.	.	916	918	ATG	1357	1359	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306L:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	M306V	0	.	.	916	918	ATG	1357	1359	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	M306I	0	.	.	916	918	ATG	1357	1359	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306I:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	D311H	0	.	.	931	933	GAC	1372	1374	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D311H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	Y319C	0	.	.	955	957	TAT	1396	1398	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	Y319N	0	.	.	955	957	TAT	1396	1398	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	D328G	0	.	.	982	984	GAT	1423	1425	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	D328Y	0	.	.	982	984	GAT	1423	1425	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328Y:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	F330V	0	.	.	988	990	TTC	1429	1431	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:F330V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	Y333C	0	.	.	997	999	TAT	1438	1440	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y333C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	Y334H	0	.	.	1000	1002	TAC	1441	1443	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y334H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	A356V	0	.	.	1066	1068	GCC	1507	1509	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A356V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	A357S	0	.	.	1069	1071	GCC	1510	1512	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A357S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	E368A	0	.	.	1102	1104	GAG	1543	1545	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E368A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	P375A	0	.	.	1123	1125	CCG	1564	1566	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P375A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	E378A	0	.	.	1132	1134	GAG	1573	1575	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E378A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	S380R	0	.	.	1138	1140	AGC	1579	1581	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S380R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	P397Q	0	.	.	1189	1191	CCG	1630	1632	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P397Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	N399H	0	.	.	1195	1197	AAC	1636	1638	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:N399H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	G406C	0	.	.	1216	1218	GGC	1657	1659	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	G406A	0	.	.	1216	1218	GGC	1657	1659	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	G406D	0	.	.	1216	1218	GGC	1657	1659	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	G406S	0	.	.	1216	1218	GGC	1657	1659	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	L413P	0	.	.	1237	1239	CTG	1678	1680	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L413P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	P446H	0	.	.	1336	1338	CCC	1777	1779	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P446H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	R460C	0	.	.	1378	1380	CGC	1819	1821	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R460C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	I465D	0	.	.	1393	1395	ATC	1834	1836	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:I465D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	R469P	0	.	.	1405	1407	CGT	1846	1848	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R469P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	R471P	0	.	.	1411	1413	CGC	1852	1854	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R471P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	Q497K	0	.	.	1489	1491	CAG	1930	1932	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497K:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	Q497R	0	.	.	1489	1491	CAG	1930	1932	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	E504Q	0	.	.	1510	1512	GAA	1951	1953	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E504Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	R507G	0	.	.	1519	1521	AGG	1960	1962	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R507G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	G745D	0	.	.	2233	2235	GGC	2674	2676	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G745D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	D959A	0	.	.	2875	2877	GAC	3316	3318	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D959A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	M1000R	0	.	.	2998	3000	ATG	3439	3441	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M1000R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1514	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3989	0.0	1	SNP	p	D1024N	0	.	.	3070	3072	GAC	3511	3513	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D1024N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	A247P	0	.	.	739	741	GCG	1105	1107	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A247P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	L251R	0	.	.	751	753	CTG	1117	1119	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L251R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	A254G	0	.	.	760	762	GCC	1126	1128	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A254G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	T270I	0	.	.	808	810	ACC	1174	1176	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:T270I:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	H285Y	0	.	.	853	855	CAT	1219	1221	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:H285Y:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	V287F	0	.	.	859	861	GTC	1225	1227	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V287F:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	G288W	0	.	.	862	864	GGG	1228	1230	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288W:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	G288V	0	.	.	862	864	GGG	1228	1230	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288V:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	Y296S	0	.	.	886	888	TAC	1252	1254	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	Y296H	0	.	.	886	888	TAC	1252	1254	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296H:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	I297L	0	.	.	889	891	ATC	1255	1257	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	I297T	0	.	.	889	891	ATC	1255	1257	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	M300R	0	.	.	898	900	ATG	1264	1266	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M300R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	R302G	0	.	.	904	906	CGG	1270	1272	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R302G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	V303G	0	.	.	907	909	GTG	1273	1275	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V303G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	A307T	0	.	.	919	921	GCG	1285	1287	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A307T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	G308D	0	.	.	922	924	GGC	1288	1290	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G308D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	Y309N	0	.	.	925	927	TAT	1291	1293	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y309N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	M310K	0	.	.	928	930	ATG	1294	1296	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M310K:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	G325S	0	.	.	973	975	GGC	1339	1341	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G325S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	W326R	0	.	.	976	978	TGG	1342	1344	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:W326R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	Y327N	0	.	.	979	981	TAC	1345	1347	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y327N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	N394D	0	.	.	1180	1182	AAC	1546	1548	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:N394D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	P398S	0	.	.	1192	1194	CCC	1558	1560	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:P398S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	Q491R	0	.	.	1471	1473	CAG	1837	1839	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Q491R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	L502P	0	.	.	1504	1506	CTC	1870	1872	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L502P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	R738Q	0	.	.	2212	2214	CGG	2578	2580	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R738Q:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	27	1512	embC	3285	3285	99.97	embC.l6.c4.ctg.1	4312	0.0	1	SNP	p	V981L	0	.	.	2941	2943	GTG	3307	3309	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V981L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	531	592	embR	1167	1167	99.91	embR.l15.c4.ctg.1	2043	0.0	0	.	p	.	0	K119fs	FSHIFT	355	355	A	812	812	A	ND	ND	ND	.	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	531	592	embR	1167	1167	99.91	embR.l15.c4.ctg.1	2043	0.0	1	SNP	p	C110Y	0	.	.	328	330	TGC	785	787	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:C110Y:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	P28S	0	.	.	82	84	CCG	520	522	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:P28S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	L35R	0	.	.	103	105	CTG	541	543	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L35R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	G42D	0	.	.	124	126	GGC	562	564	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:G42D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	D56Y	0	.	.	166	168	GAC	604	606	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D56Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	D58G	0	.	.	172	174	GAC	610	612	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D58G:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	W69C	0	.	.	205	207	TGG	643	645	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:W69C:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	H102P	0	.	.	304	306	CAC	742	744	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:H102P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	Y141N	0	.	.	421	423	TAC	859	861	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Y141N:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	V179F	0	.	.	535	537	GTC	973	975	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:V179F:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	T186P	0	.	.	556	558	ACG	994	996	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T186P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	T189R	0	.	.	565	567	ACG	1003	1005	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T189R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	Q246P	0	.	.	736	738	CAG	1174	1176	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q246P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	Q254P	0	.	.	760	762	CAG	1198	1200	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q254P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	L267V	0	.	.	799	801	CTG	1237	1239	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L267V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	S329P	0	.	.	985	987	TCA	1423	1425	TCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:S329P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	A341V	0	.	.	1021	1023	GCA	1459	1461	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A341V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	N345K	0	.	.	1033	1035	AAC	1471	1473	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:N345K:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	A352E	0	.	.	1054	1056	GCG	1492	1494	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A352E:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	M372R	0	.	.	1114	1116	ATG	1552	1554	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:M372R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	A395D	0	.	.	1183	1185	GCC	1621	1623	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A395D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	C403Y	0	.	.	1207	1209	TGT	1645	1647	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:C403Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	746	ethA_2	1470	1470	100.0	ethA_2.l15.c4.ctg.1	2403	0.0	1	SNP	p	F480S	0	.	.	1438	1440	TTC	1876	1878	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:F480S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	T20P	0	.	.	58	60	ACT	467	469	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:T20P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	E40Q	0	.	.	118	120	GAG	527	529	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40Q:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	E40G	0	.	.	118	120	GAG	527	529	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	I43T	0	.	.	127	129	ATC	536	538	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43T:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	I43A	0	.	.	127	129	ATC	536	538	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	I43S	0	.	.	127	129	ATC	536	538	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43S:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	R49P	0	.	.	145	147	CGG	554	556	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	R49W	0	.	.	145	147	CGG	554	556	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	L56V	0	.	.	166	168	CTG	575	577	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:L56V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	R91W	0	.	.	271	273	CGG	680	682	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R91W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	S150C	0	.	.	448	450	AGC	857	859	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150C:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	S150G	0	.	.	448	450	AGC	857	859	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	E153G	0	.	.	457	459	GAG	866	868	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	E153A	0	.	.	457	459	GAG	866	868	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	640	folC	1464	1464	100.0	folC.l6.c4.ctg.1	2315	0.0	1	SNP	p	A420V	0	.	.	1258	1260	GCG	1667	1669	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:A420V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	0	.	p	.	0	E92D	NONSYN	274	276	GAA	826	828	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	G30R	0	.	.	88	90	GGT	640	642	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G30R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	G37V	0	.	.	109	111	GGA	661	663	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G37V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	W45S	0	.	.	133	135	TGG	685	687	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	W45C	0	.	.	133	135	TGG	685	687	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	R47Q	0	.	.	139	141	CGG	691	693	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:R47Q:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	H48Y	0	.	.	142	144	CAT	694	696	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:H48Y:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	L49F	0	.	.	145	147	CTA	697	699	CTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L49F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	I55S	0	.	.	163	165	ATC	715	717	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:I55S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	D67H	0	.	.	199	201	GAT	751	753	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:D67H:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	S70R	0	.	.	208	210	AGC	760	762	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:S70R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	G71V	0	.	.	211	213	GGA	763	765	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G71V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	P75S	0	.	.	223	225	CCG	775	777	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P75S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	L79S	0	.	.	235	237	TTG	787	789	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	L79F	0	.	.	235	237	TTG	787	789	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	P84L	0	.	.	250	252	CCG	802	804	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84L:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	P84C	0	.	.	250	252	CCG	802	804	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	G117E	0	.	.	349	351	GGG	901	903	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G117E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	V124G	0	.	.	370	372	GTG	922	924	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V124G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAA	931	933	CAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:Q127P:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	A134E	0	.	.	400	402	GCG	952	954	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A134E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	A138E	0	.	.	412	414	GCG	964	966	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A138E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	967	969	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V139A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	W148R	0	.	.	442	444	TGG	994	996	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W148R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	G164C	0	.	.	490	492	GGC	1042	1044	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G164C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	A183E	0	.	.	547	549	GCG	1099	1101	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	A183T	0	.	.	547	549	GCG	1099	1101	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	V188G	0	.	.	562	564	GTG	1114	1116	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	V188M	0	.	.	562	564	GTG	1114	1116	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188M:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	539	416	gidB	675	675	99.7	gidB.l15.c4.ctg.1	1525	0.0	1	SNP	p	A200E	0	.	.	598	600	GCG	1150	1152	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A200E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	0	.	p	.	0	E21Q	NONSYN	61	63	GAG	310	312	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	0	.	p	.	0	S95T	NONSYN	283	285	AGC	532	534	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	0	.	p	.	0	G668D	NONSYN	2002	2004	GGC	2251	2253	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	A74S	0	.	.	220	222	GCC	469	471	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A74S:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	T80A	0	.	.	238	240	ACC	487	489	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:T80A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	G88C	0	.	.	262	264	GGC	511	513	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88C:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	G88A	0	.	.	262	264	GGC	511	513	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	D89V	0	.	.	265	267	GAC	514	516	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	D89G	0	.	.	265	267	GAC	514	516	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	D89N	0	.	.	265	267	GAC	514	516	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	A90V	0	.	.	268	270	GCG	517	519	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	A90G	0	.	.	268	270	GCG	517	519	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	S91P	0	.	.	271	273	TCG	520	522	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:S91P:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	D94Y	0	.	.	280	282	GAC	529	531	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94Y:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	D94A	0	.	.	280	282	GAC	529	531	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	D94G	0	.	.	280	282	GAC	529	531	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	D94V	0	.	.	280	282	GAC	529	531	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	D94T	0	.	.	280	282	GAC	529	531	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94T:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	D94N	0	.	.	280	282	GAC	529	531	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1392	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3051	0.0	1	SNP	p	P102H	0	.	.	304	306	CCC	553	555	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:P102H:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1304	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2966	0.0	1	SNP	p	V340L	0	.	.	1018	1020	GTG	1520	1522	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:V340L:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1304	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2966	0.0	1	SNP	p	D500H	0	.	.	1498	1500	GAC	2000	2002	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:D500H:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1304	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2966	0.0	1	SNP	p	N538K	0	.	.	1612	1614	AAC	2114	2116	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538K:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1304	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2966	0.0	1	SNP	p	N538D	0	.	.	1612	1614	AAC	2114	2116	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1304	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2966	0.0	1	SNP	p	T539P	0	.	.	1615	1617	ACC	2117	2119	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539P:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1304	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2966	0.0	1	SNP	p	T539N	0	.	.	1615	1617	ACC	2117	2119	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539N:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1304	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2966	0.0	1	SNP	p	E540V	0	.	.	1618	1620	GAA	2120	2122	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540V:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1304	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	2966	0.0	1	SNP	p	E540D	0	.	.	1618	1620	GAA	2120	2122	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	388	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1632	0.0	1	SNP	p	I16T	0	.	.	46	48	ATC	487	489	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I16T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	388	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1632	0.0	1	SNP	p	I21V	0	.	.	61	63	ATC	502	504	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21V:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	388	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1632	0.0	1	SNP	p	I21T	0	.	.	61	63	ATC	502	504	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	388	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1632	0.0	1	SNP	p	I47T	0	.	.	139	141	ATT	580	582	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I47T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	388	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1632	0.0	1	SNP	p	V78A	0	.	.	232	234	GTG	673	675	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:V78A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	388	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1632	0.0	1	SNP	p	S94A	0	.	.	280	282	TCG	721	723	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:S94A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	388	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1632	0.0	1	SNP	p	I95P	0	.	.	283	285	ATT	724	726	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I95P:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	388	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1632	0.0	1	SNP	p	G141E	0	.	.	421	423	GGA	862	864	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:G141E:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	388	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1632	0.0	1	SNP	p	I194T	0	.	.	580	582	ATC	1021	1023	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I194T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1098	iniA	1923	1923	100.0	iniA.l6.c4.ctg.1	2770	0.0	1	SNP	p	P3A	0	.	.	7	9	CCC	346	348	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:P3A:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1098	iniA	1923	1923	100.0	iniA.l6.c4.ctg.1	2770	0.0	1	SNP	p	G308R	0	.	.	922	924	GGG	1261	1263	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:G308R:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1098	iniA	1923	1923	100.0	iniA.l6.c4.ctg.1	2770	0.0	1	SNP	p	S501W	0	.	.	1501	1503	TCG	1840	1842	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:S501W:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1098	iniA	1923	1923	100.0	iniA.l6.c4.ctg.1	2770	0.0	1	SNP	p	R537H	0	.	.	1609	1611	CGC	1948	1950	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:R537H:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	27	514	iniB	1440	1440	100.0	iniB.l6.c17.ctg.1	2261	0.0	1	SNP	p	A47T	0	.	.	139	141	GCC	499	501	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniB.3004135.AL123456.3.409361_410801.5509:1:1:A47T:.:b'Point mutations in M. tuberculosis iniB shown to confer resistance to ethambutol.'	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	704	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	2332	0.0	1	SNP	p	W83G	0	.	.	247	249	TGG	698	700	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:W83G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	704	iniC	1482	1482	100.0	iniC.l15.c4.ctg.1	2332	0.0	1	SNP	p	P248A	0	.	.	742	744	CCG	1193	1195	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:P248A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	508	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2059	0.0	1	SNP	p	D66N	0	.	.	196	198	GAT	550	552	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:D66N:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	508	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2059	0.0	1	SNP	p	R121K	0	.	.	361	363	AGG	715	717	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:R121K:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	508	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2059	0.0	1	SNP	p	G269S	0	.	.	805	807	GGT	1159	1161	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G269S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	508	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2059	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	1288	1290	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	508	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2059	0.0	1	SNP	p	G387D	0	.	.	1159	1161	GGC	1513	1515	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G387D:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	508	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2059	0.0	1	SNP	p	F413L	0	.	.	1237	1239	TTC	1591	1593	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:F413L:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	0	.	p	.	0	R463L	NONSYN	1387	1389	CGG	1730	1732	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	G33V	0	.	.	97	99	GGC	440	442	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G33V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	W91R	0	.	.	271	273	TGG	614	616	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:W91R:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	A110V	0	.	.	328	330	GCC	671	673	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A110V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	G111S	0	.	.	331	333	GGC	674	676	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G111S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	G125S	0	.	.	373	375	GGC	716	718	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G125S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	M126I	0	.	.	376	378	ATG	719	721	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:M126I:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAG	722	724	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q127P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	D142G	0	.	.	424	426	GAC	767	769	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:D142G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	L147P	0	.	.	439	441	CTG	782	784	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:L147P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	A264V	0	.	.	790	792	GCG	1133	1135	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A264V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	A312P	0	.	.	934	936	GCG	1277	1279	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A312P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	S315G	0	.	.	943	945	AGC	1286	1288	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	S315N	0	.	.	943	945	AGC	1286	1288	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315N:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	S315T	0	.	.	943	945	AGC	1286	1288	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315T:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	H417Q	0	.	.	1249	1251	CAC	1592	1594	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:H417Q:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	Q461P	0	.	.	1381	1383	CAG	1724	1726	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q461P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	G490S	0	.	.	1468	1470	GGC	1811	1813	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G490S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	N508D	0	.	.	1522	1524	AAC	1865	1867	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N508D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	E607A	0	.	.	1819	1821	GAG	2162	2164	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:E607A:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1038	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	2913	0.0	1	SNP	p	N660D	0	.	.	1978	1980	AAC	2321	2323	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N660D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
mfpA.3003035.AL123456.1.3773015_3773567.4588	mfpA.3003035.AL123456.1.3773015_3773567.4588	1	0	27	328	mfpA	552	552	100.0	mfpA.l15.c4.ctg.1	1446	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mfpA;b'mfpA is a qnr homolog and a pentapeptide repeat protein that confers resistance to fluoroquinolones in Mycolicibacterium smegmatis.'
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	539	712	mshA_1	1443	1443	99.93	mshA_1.l15.c17.ctg.1	2093	0.0	0	.	p	.	0	A187V	NONSYN	559	561	GCA	891	893	GTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	539	712	mshA_1	1443	1443	99.93	mshA_1.l15.c17.ctg.1	2093	0.0	1	SNP	p	F355S	0	.	.	1063	1065	TTC	1395	1397	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	mshA.3005108.NC_000962.3.575347_576790.6150:1:1:F355S:.:b'Mutations in Mycobacterium tuberculosis mshA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	27	642	murA_4	1257	1257	100.0	murA_4.l15.c4.ctg.1	2124	0.0	1	SNP	p	C117D	1	.	.	349	351	GAC	833	835	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	murA.3003784.HE608151.1.1472985_1474242.3555:1:1:C117D:.:b'Mycobacterium tuberculosis murA confers intrinsic resistance to fosfomycin. The presence of an aspartic acid residue in place of the critical cysteine at position 117 that enables fosfomycin binding is believed to be responsible for this intrinsic resistance.'	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	M1S	0	.	.	1	3	ATG	240	242	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M1S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A3E	0	.	.	7	9	GCG	246	248	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A3E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L4W	0	.	.	10	12	TTG	249	251	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L4W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	I5S	0	.	.	13	15	ATC	252	254	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I5S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V7G	0	.	.	19	21	GTC	258	260	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V7D	0	.	.	19	21	GTC	258	260	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V7F	0	.	.	19	21	GTC	258	260	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D8Y	0	.	.	22	24	GAC	261	263	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D8Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V9G	0	.	.	25	27	GTG	264	266	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V9A	0	.	.	25	27	GTG	264	266	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	Q10P	0	.	.	28	30	CAG	267	269	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	Q10K	0	.	.	28	30	CAG	267	269	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	Q10R	0	.	.	28	30	CAG	267	269	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D12A	0	.	.	34	36	GAC	273	275	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D12N	0	.	.	34	36	GAC	273	275	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D12E	0	.	.	34	36	GAC	273	275	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	C14R	0	.	.	40	42	TGC	279	281	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	C14Y	0	.	.	40	42	TGC	279	281	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	G17S	0	.	.	49	51	GGC	288	290	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	G17D	0	.	.	49	51	GGC	288	290	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L19P	0	.	.	55	57	CTG	294	296	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L19P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	G23V	0	.	.	67	69	GGT	306	308	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G23V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A26G	0	.	.	76	78	GCG	315	317	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A26G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L27P	0	.	.	79	81	CTG	318	320	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L27P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	Y34S	0	.	.	100	102	TAC	339	341	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y34S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	Y41H	0	.	.	121	123	TAC	360	362	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y41H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V45G	0	.	.	133	135	GTG	372	374	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V45G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A46V	0	.	.	136	138	GCA	375	377	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A46E	0	.	.	136	138	GCA	375	377	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T47S	0	.	.	139	141	ACC	378	380	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T47A	0	.	.	139	141	ACC	378	380	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T47P	0	.	.	139	141	ACC	378	380	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D49V	0	.	.	145	147	GAC	384	386	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D49A	0	.	.	145	147	GAC	384	386	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	H51Q	0	.	.	151	153	CAC	390	392	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	H51Y	0	.	.	151	153	CAC	390	392	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D53A	0	.	.	157	159	GAC	396	398	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D53A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	P54T	0	.	.	160	162	CCG	399	401	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	P54L	0	.	.	160	162	CCG	399	401	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	H57Q	0	.	.	169	171	CAC	408	410	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	H57D	0	.	.	169	171	CAC	408	410	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	F58L	0	.	.	172	174	TTC	411	413	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F58L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	P62H	0	.	.	184	186	CCG	423	425	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P62H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	S66P	0	.	.	196	198	TCG	435	437	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S66P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	S67P	0	.	.	199	201	TCG	438	440	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S67P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	W68L	0	.	.	202	204	TGG	441	443	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	W68R	0	.	.	202	204	TGG	441	443	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	W68C	0	.	.	202	204	TGG	441	443	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	W68G	0	.	.	202	204	TGG	441	443	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	W68S	0	.	.	202	204	TGG	441	443	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	P69R	0	.	.	205	207	CCA	444	446	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P69R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	H71E	0	.	.	211	213	CAT	450	452	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H71E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	C72R	0	.	.	214	216	TGC	453	455	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	C72W	0	.	.	214	216	TGC	453	455	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T76I	0	.	.	226	228	ACT	465	467	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76I:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T76P	0	.	.	226	228	ACT	465	467	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	G78D	0	.	.	232	234	GGC	471	473	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G78D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	H82R	0	.	.	244	246	CAT	483	485	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H82R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L85R	0	.	.	253	255	CTG	492	494	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L85P	0	.	.	253	255	CTG	492	494	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	I90S	0	.	.	268	270	ATC	507	509	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I90S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	F94P	0	.	.	280	282	TTC	519	521	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F94P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	K96Q	0	.	.	286	288	AAG	525	527	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	K96N	0	.	.	286	288	AAG	525	527	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	K96M	0	.	.	286	288	AAG	525	527	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	K96E	0	.	.	286	288	AAG	525	527	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	G97S	0	.	.	289	291	GGT	528	530	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G97S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T100P	0	.	.	298	300	ACC	537	539	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T100P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A102T	0	.	.	304	306	GCG	543	545	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A102V	0	.	.	304	306	GCG	543	545	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	Y103S	0	.	.	307	309	TAC	546	548	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	Y103H	0	.	.	307	309	TAC	546	548	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	S104C	0	.	.	310	312	AGC	549	551	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S104C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L116R	0	.	.	346	348	CTG	585	587	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L116R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	N118T	0	.	.	352	354	AAT	591	593	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:N118T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	W119R	0	.	.	355	357	TGG	594	596	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W119R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	R121P	0	.	.	361	363	CGG	600	602	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R121P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V125D	0	.	.	373	375	GTC	612	614	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V125D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	G132S	0	.	.	394	396	GGT	633	635	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G132S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	I133T	0	.	.	397	399	ATT	636	638	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I133T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A134V	0	.	.	400	402	GCC	639	641	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A134V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T135P	0	.	.	403	405	ACC	642	644	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T135P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D136N	0	.	.	406	408	GAT	645	647	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D136H	0	.	.	406	408	GAT	645	647	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	D136Y	0	.	.	406	408	GAT	645	647	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	H137R	0	.	.	409	411	CAT	648	650	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	H137P	0	.	.	409	411	CAT	648	650	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	C138W	0	.	.	412	414	TGT	651	653	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	C138Y	0	.	.	412	414	TGT	651	653	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	C138S	0	.	.	412	414	TGT	651	653	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	654	656	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V139L	0	.	.	415	417	GTG	654	656	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V139M	0	.	.	415	417	GTG	654	656	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	R140G	0	.	.	418	420	CGC	657	659	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R140G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	Q141P	0	.	.	421	423	CAG	660	662	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q141P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T142M	0	.	.	424	426	ACG	663	665	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T142K	0	.	.	424	426	ACG	663	665	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A146T	0	.	.	436	438	GCG	675	677	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A146T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	R154G	0	.	.	460	462	AGG	699	701	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R154G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V155G	0	.	.	463	465	GTG	702	704	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V155G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V157G	0	.	.	469	471	GTG	708	710	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V157G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L159R	0	.	.	475	477	CTG	714	716	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L159R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T160P	0	.	.	478	480	ACA	717	719	ACA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T160P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A161G	0	.	.	481	483	GCG	720	722	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A161P	0	.	.	481	483	GCG	720	722	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	S164P	0	.	.	490	492	TCG	729	731	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S164P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	T168N	0	.	.	502	504	ACC	741	743	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T168N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A171T	0	.	.	511	513	GCG	750	752	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A171V	0	.	.	511	513	GCG	750	752	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	A171P	0	.	.	511	513	GCG	750	752	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L172A	0	.	.	514	516	CTG	753	755	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L172P	0	.	.	514	516	CTG	753	755	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	E174G	0	.	.	520	522	GAG	759	761	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:E174G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	M175V	0	.	.	523	525	ATG	762	764	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M175V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	V180F	0	.	.	538	540	GTC	777	779	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V180F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	358	pncA	561	561	100.0	pncA.l6.c4.ctg.1	1085	0.0	1	SNP	p	L182S	0	.	.	544	546	TTG	783	785	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L182S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
ribD.3004184.AL123456.3.2986838_2987615.5511	ribD.3004184.AL123456.3.2986838_2987615.5511	1	1	27	330	ribD	777	777	100.0	ribD.l15.c4.ctg.1	1663	0.0	1	SNP	p	G8R	0	.	.	22	24	GGA	580	582	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ribD.3004184.AL123456.3.2986838_2987615.5511:1:1:G8R:.:b'ribD is a Mycobacterium tuberculosis riboflavin biosynthesis enzyme. Point mutations in ribD cause enzyme overexpression, which allows the C-terminal reductase domain to act as an alternative dihydrofolate reductase. Thus, mutations in ribD confer resistance to DHFR inhibitors such as para-aminosalicylic acid.'	Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	V146F	0	.	.	436	438	GTG	855	857	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:V146F:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	S450L	0	.	.	1348	1350	TCG	1767	1769	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:S450L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	F505L	0	.	.	1513	1515	TTC	1932	1934	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:F505L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	T508H	0	.	.	1522	1524	ACG	1941	1943	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508H:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	T508N	0	.	.	1522	1524	ACG	1941	1943	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508N:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	T508P	0	.	.	1522	1524	ACG	1941	1943	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508P:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	T508S	0	.	.	1522	1524	ACG	1941	1943	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508S:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	T508A	0	.	.	1522	1524	ACG	1941	1943	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508A:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	L511R	1	.	.	1531	1533	CGC	1950	1952	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:L511R:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	D516G	1	.	.	1546	1548	GGC	1965	1967	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:D516G:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1688	rpoB_1	3519	3519	99.97	rpoB_1.l15.c4.ctg.1	4415	0.0	1	SNP	p	H526T	1	.	.	1576	1578	ACC	1995	1997	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:H526T:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	744	rpsA	1446	1446	99.93	rpsA.l6.c30.ctg.1	2404	0.0	1	SNP	p	D123A	0	.	.	367	369	GAC	778	780	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D123A:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	744	rpsA	1446	1446	99.93	rpsA.l6.c30.ctg.1	2404	0.0	1	SNP	p	S324F	0	.	.	970	972	TCC	1381	1383	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:S324F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	744	rpsA	1446	1446	99.93	rpsA.l6.c30.ctg.1	2404	0.0	1	SNP	p	E325K	0	.	.	973	975	GAG	1384	1386	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:E325K:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	744	rpsA	1446	1446	99.93	rpsA.l6.c30.ctg.1	2404	0.0	1	SNP	p	G341R	0	.	.	1021	1023	GGC	1432	1434	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:G341R:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	744	rpsA	1446	1446	99.93	rpsA.l6.c30.ctg.1	2404	0.0	1	SNP	p	D342N	0	.	.	1024	1026	GAC	1435	1437	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D342N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	744	rpsA	1446	1446	99.93	rpsA.l6.c30.ctg.1	2404	0.0	1	SNP	p	D343N	0	.	.	1027	1029	GAC	1438	1440	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D343N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	744	rpsA	1446	1446	99.93	rpsA.l6.c30.ctg.1	2404	0.0	1	SNP	p	A344P	0	.	.	1030	1032	GCG	1441	1443	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:A344P:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	744	rpsA	1446	1446	99.93	rpsA.l6.c30.ctg.1	2404	0.0	1	SNP	p	I351F	0	.	.	1051	1053	ATC	1462	1464	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:I351F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	539	300	rpsL	375	375	99.73	rpsL.l6.c4.ctg.1	1213	0.0	1	SNP	p	K43R	1	K43R	NONSYN	127	129	AAG	569	571	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K43R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	539	300	rpsL	375	375	99.73	rpsL.l6.c4.ctg.1	1213	0.0	1	SNP	p	T40I	0	.	.	118	120	ACC	560	562	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:T40I:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	539	300	rpsL	375	375	99.73	rpsL.l6.c4.ctg.1	1213	0.0	1	SNP	p	K88Q	0	.	.	262	264	AAG	704	706	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88Q:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	539	300	rpsL	375	375	99.73	rpsL.l6.c4.ctg.1	1213	0.0	1	SNP	p	K88R	0	.	.	262	264	AAG	704	706	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	334	97.31	rrsB_9.l15.c4.ctg.1	549	0.0	0	.	n	.	0	T1207C	SNP	1207	1207	T	87	87	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	334	97.31	rrsB_9.l15.c4.ctg.1	549	0.0	0	.	n	.	0	G1214A	SNP	1214	1214	G	94	94	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	334	97.31	rrsB_9.l15.c4.ctg.1	549	0.0	0	.	n	.	0	T1224.	DEL	1224	1224	T	103	103	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	334	97.31	rrsB_9.l15.c4.ctg.1	549	0.0	0	.	n	.	0	C1227A	SNP	1227	1227	C	106	106	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	334	97.31	rrsB_9.l15.c4.ctg.1	549	0.0	0	.	n	.	0	G1380A	SNP	1380	1380	G	259	259	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	334	97.31	rrsB_9.l15.c4.ctg.1	549	0.0	0	.	n	.	0	T1394C	SNP	1394	1394	T	273	273	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	334	97.31	rrsB_9.l15.c4.ctg.1	549	0.0	0	.	n	.	0	T1396.	DEL	1396	1396	T	274	274	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	334	97.31	rrsB_9.l15.c4.ctg.1	549	0.0	0	.	n	.	0	C1406T	SNP	1406	1406	C	284	284	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	334	97.31	rrsB_9.l15.c4.ctg.1	549	0.0	1	SNP	n	C1439U	0	.	.	1439	1439	C	317	317	C	ND	ND	ND	rrsB.3003540.X52922.1.0_1454.4148:0:0:C1439U:.:b'Point mutations in the highly conserved helix 44 of the 16S rrsB rRNA gene of Mycolicibacterium smegmatis can confer resistance to hygromycin B. Resistance against hygromycin B is the result of conformational alterations that distorts a strong hydrogen bond leading to a change in the local geometry of the hygromycin B binding site.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	C38T	SNP	38	38	C	392	392	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	T41C	SNP	41	41	T	395	395	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	G47A	SNP	47	47	G	401	401	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	G49A	SNP	49	49	G	403	403	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	T101C	SNP	101	101	T	455	455	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	A134G	SNP	134	134	A	488	488	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	C138G	SNP	138	138	C	492	492	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	C140A	SNP	140	140	C	494	494	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	G144A	SNP	144	144	G	497	497	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	T146G	SNP	146	146	T	499	499	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	C150T	SNP	150	150	C	503	503	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	G155.	DEL	155	155	G	507	507	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	C157T	SNP	157	157	C	509	509	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	G160T	SNP	160	160	G	512	512	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	G165T	SNP	165	165	G	517	517	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	.170GC	INS	170	170	A	523	523	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	T176A	SNP	176	176	T	530	530	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	G190A	SNP	190	190	G	544	544	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	T223C	SNP	223	223	T	577	577	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	329	91.84	rrsB_9.l15.c4.ctg.2	683	0.0	0	.	n	.	0	A265T	SNP	265	265	A	619	619	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	218	98.62	rrsB_9.l15.c4.ctg.3	220	0.0	0	.	n	.	0	A549T	SNP	549	549	A	19	19	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	218	98.62	rrsB_9.l15.c4.ctg.3	220	0.0	0	.	n	.	0	A555G	SNP	555	555	A	25	25	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	512	74	rrsB_9	1454	218	98.62	rrsB_9.l15.c4.ctg.3	220	0.0	0	.	n	.	0	G567A	SNP	567	567	G	37	37	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	0	.	n	.	0	T1248C	SNP	1248	1248	T	87	87	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	0	.	n	.	0	G1254T	SNP	1254	1254	G	93	93	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	0	.	n	.	0	G1255A	SNP	1255	1255	G	94	94	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	0	.	n	.	0	T1265.	DEL	1265	1265	T	103	103	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	0	.	n	.	0	C1268A	SNP	1268	1268	C	106	106	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	0	.	n	.	0	G1421A	SNP	1421	1421	G	259	259	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	0	.	n	.	0	T1437.	DEL	1437	1437	T	274	274	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	0	.	n	.	0	C1447T	SNP	1447	1447	C	284	284	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	1	SNP	n	G1475U	0	.	.	1475	1475	G	312	312	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475U:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	367	97.55	rrsB_13.l15.c4.ctg.1	484	0.0	1	SNP	n	G1475A	0	.	.	1475	1475	G	312	312	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475A:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	C81T	SNP	81	81	C	442	442	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	T82C	SNP	82	82	T	443	443	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	G90A	SNP	90	90	G	451	451	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	T142C	SNP	142	142	T	503	503	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	A175G	SNP	175	175	A	536	536	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	A180G	SNP	180	180	A	541	541	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	C181A	SNP	181	181	C	542	542	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	G185A	SNP	185	185	G	545	545	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	T187G	SNP	187	187	T	547	547	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	C191T	SNP	191	191	C	551	551	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	C198T	SNP	198	198	C	557	557	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	G201T	SNP	201	201	G	560	560	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	A204G	SNP	204	204	A	563	563	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	G206T	SNP	206	206	G	565	565	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	.211GC	INS	211	211	A	571	571	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	T217A	SNP	217	217	T	578	578	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	G231A	SNP	231	231	G	592	592	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	T264C	SNP	264	264	T	625	625	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	369	92.99	rrsB_13.l15.c4.ctg.2	731	0.0	0	.	n	.	0	A306T	SNP	306	306	A	667	667	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	220	98.64	rrsB_13.l15.c4.ctg.3	220	0.0	0	.	n	.	0	A590T	SNP	590	590	A	19	19	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	220	98.64	rrsB_13.l15.c4.ctg.3	220	0.0	0	.	n	.	0	A596G	SNP	596	596	A	25	25	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	98	rrsB_13	1528	220	98.64	rrsB_13.l15.c4.ctg.3	220	0.0	0	.	n	.	0	G608A	SNP	608	608	G	37	37	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	0	.	p	.	0	F239S	NONSYN	715	717	TTC	1188	1190	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	T22A	0	.	.	64	66	ACC	537	539	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T22A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	Y36C	0	.	.	106	108	TAT	579	581	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:Y36C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	H75N	0	.	.	223	225	CAC	696	698	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H75N:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	V77F	0	.	.	229	231	GTC	702	704	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:V77F:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	W83C	0	.	.	247	249	TGG	720	722	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W83C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	G91R	0	.	.	271	273	GGG	744	746	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:G91R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	W101R	0	.	.	301	303	TGG	774	776	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W101R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	S105P	0	.	.	313	315	TCC	786	788	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:S105P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	R126Q	0	.	.	376	378	CGG	849	851	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R126Q:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	F152V	0	.	.	454	456	TTC	927	929	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:F152V:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	C161T	0	.	.	481	483	TGT	954	956	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:C161T:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	T202A	0	.	.	604	606	ACC	1077	1079	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T202A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	H207R	0	.	.	619	621	CAC	1092	1094	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H207R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	P224L	0	.	.	670	672	CCG	1143	1145	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:P224L:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	539	416	thyA	792	792	99.87	thyA.l15.c4.ctg.1	1669	0.0	1	SNP	p	R235P	0	.	.	703	705	CGG	1176	1178	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R235P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	R14W	0	.	.	40	42	CGG	540	542	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:R14W:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	A67E	0	.	.	199	201	GCG	699	701	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A67E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	K69E	0	.	.	205	207	AAA	705	707	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:K69E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	A91E	0	.	.	271	273	GCA	771	773	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A91E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	L118P	0	.	.	352	354	CTG	852	854	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L118P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	V128E	0	.	.	382	384	GTG	882	884	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:V128E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	L150P	0	.	.	448	450	CTG	948	950	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L150P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	P183L	0	.	.	547	549	CCG	1047	1049	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:P183L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	F185L	0	.	.	553	555	TTT	1053	1055	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:F185L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	N236K	0	.	.	706	708	AAT	1206	1208	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:N236K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	406	tlyA	807	807	100.0	tlyA.l6.c4.ctg.1	1810	0.0	1	SNP	p	E238K	0	.	.	712	714	GAG	1212	1214	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:E238K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
